Skip to main content

Day: July 9, 2020

Vow ASA : Vow ASA awarded grants and loans to boost its plastic waste to energy projects

Innovation Norway, the government’s instrument for innovation and development of Norwegian enterprises and industry, has awarded grants and loans to Scanship AS, a subsidiary of Vow ASA, to further commercialize the application of its patented pyrolysis technology for chemical recycling of plastic waste.The loans and grants, a total of NOK 19.4 million will be used to build a plant in Norway to demonstrate the conversion of plastic waste into energy.“We are grateful for the continuous support from Innovation Norway in developing technologies to enhance circular economy and for climate change mitigation,” says Henrik Badin, CEO of Vow ASA.He adds that the support from Innovation Norway will accelerate Vow’s efforts to commercialize its unique technology to valorize syngas from pyrolysis reactors, which is a key component in Vow’s existing...

Continue reading

Park Aerospace Corp. Reports First Quarter Results

NEWTON, Kan., July 09, 2020 (GLOBE NEWSWIRE) — Park Aerospace Corp. (NYSE-PKE) reported results for the 2021 fiscal year first quarter ended May 31, 2020. As previously reported, Park completed the sale of its Electronics Business to AGC Inc. on December 4, 2018. Therefore, current costs relating to the sale of the Electronics Business are reported as discontinued operations. Continuing operations discussed below refer to Park’s Aerospace Business unless otherwise indicated.The Company will conduct a conference call to discuss its financial results and other matters at 11:00 a.m. EDT today. A live audio webcast of the event, along with presentation materials, will be available at https://edge.media-server.com/mmc/p/xsr6eshy at 11:00 a.m. EDT today. The presentation materials will also be available at approximately 9:00 a.m. EDT...

Continue reading

QMX Gold Reports Strong Results From Bonnefond Shear Zones

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) — QMX Gold Corporation (“QMX” or the “Company”) (TSX:V:QMX) is pleased to release further assay results from the Winter 2020 infill drilling program from the Bonnefond Deposit (Table 1). The Bonnefond Deposit is located in the Val d’Or East Zone of QMX’s extensive land package in Val d’Or, Quebec (Figure 1).Highlights include (Grades are uncut; lengths are measured along the holes, Table 1):DDH 17315-20-109 returned 6.02g/t Au over 4.0m in a shear zone south of the Bonnefond intrusiveDDH 17315-20-110 returned 21.29g/t Au over 4.5m in a shear zone south of the Bonnefond intrusiveDDH 17315-20-113 returned 4.75g/t Au over 7.0m and 3.73g/t Au over 4.5m in two distinct shear zones to the north of the Bonnefond intrusive“We are very happy to present fantastic results to the public again,” says Dr....

Continue reading

ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease

TORONTO and CAMBRIDGE, Mass., July 09, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with unique, core technology to predict novel targets (peptide antigens) on the molecular surface of complex, misfolded proteins, and BC Neuroimmunology Lab (BCNI), have entered into a revenue-sharing joint venture (JV) agreement to develop and offer highly accurate and objective tests for detection, diagnosis and monitoring of Alzheimer’s disease (AD).Significant progress has been made over the past several years to advance a more precise diagnosis of AD. In particular, introduction of the A/T/N (amyloid/tau/neurodegeneration) criteria two years ago offered an unbiased approach for the objective biological diagnosis of AD1. However, the A/T/N diagnostic approach, until recently, required either costly PET...

Continue reading

HEXO launches medical cannabis products in Israel

OTTAWA, July 09, 2020 (GLOBE NEWSWIRE) — HEXO Corp (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) is proud to announce that it has launched medical cannabis products in Israel through a 24-month agreement with leading Israeli medical cannabis company, Breath of Life International Ltd. (“BOL”).“For the first time, HEXO’s high-quality medical cannabis is available to medical patients outside of Canada,” said Sebastien St-Louis, CEO and co-founder of HEXO. “Launching the HEXO brand in Israel is a testament to the continued work we are doing to expand our international footprint and find new markets for our award-winning products.”HEXO completed the first shipment of 493 kilograms amidst tightening international borders, a significant reduction in air cargo availability, and increased safety measures within its facilities due to...

Continue reading

HEXO lance des produits de cannabis à des fins médicales en Israël

OTTAWA, 09 juill. 2020 (GLOBE NEWSWIRE) — HEXO Corp (TSX : HEXO ; NYSE : HEXO) (« HEXO » ou la « Société ») a le plaisir d’annoncer le lancement de produits de cannabis à des fins médicales en Israël dans le cadre d’un accord conclu pour une durée de 24 mois avec Breath of Life International Ltd. (« BOL »), une entreprise israélienne leader dans le secteur du cannabis médical.« Pour la première fois, le cannabis médical de qualité supérieure de HEXO est accessible aux patients médicaux à l’extérieur du Canada », a déclaré Sébastien St-Louis, PDG et co-fondateur de HEXO. « Le lancement de la marque HEXO en Israël atteste de la poursuite de notre démarche visant à étendre notre empreinte internationale et à trouver de nouveaux marchés pour nos produits primés ». HEXO a effectué la première livraison de 493 kilogrammes...

Continue reading

CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that its paper ‘Rapid Large-Scale COVID-19 Testing During Shortages’ has been published in Diagnostics (www.mdpi.com/journal/diagnostics), an international peer-reviewed open access journal on medical diagnosis. The paper describes innovative testing solutions in the fight against COVID-19 pandemic and contributes to the global understanding of the novel Coronavirus. Furthermore, it discusses the Company’s science-backed Coronavirus initiatives, and how these can provide a testing blueprint for the medical community.Prof. Arndt Rolfs, CEO of CENTOGENE, said, “Over the past months, we have been working tirelessly to ensure that we are providing...

Continue reading

Electromedical Technologies, Inc. Announces 22% Increase in First Quarter Revenues Over the Same Period the Previous Year

SCOTTSDALE, Ariz., July 09, 2020 (GLOBE NEWSWIRE) — Electromedical Technologies, Inc. (OTC: ELCQ) (the “Company”), developer and manufacturer of the WellnessPro®, an FDA cleared bioelectronic device designed to relieve chronic, intractable and acute pain, is pleased to announce a 22% increase in its first quarter 2020 revenues over the same period in 2019. In addition, the company narrowed their loss by more than 44%.Matthew Wolfson, CEO of ELCQ, commented, “Q1 2020 represents a turning point for Electromedical Technologies, where we demonstrated strong organic demand for our WellnessPro® product. We believe that many people suffering from chronic, acute and intractable pain, have sought out pain relief alternatives while sheltering in place due to the COVID-19 pandemic. Our WellnessPro® product provides the kind of in-home bioelectronic...

Continue reading

Cash flows – Nykredit Realkredit A/S

To the Nasdaq Copenhagen9 July 2020  Cash flowsPursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes cash flows on open and closed annuity, index-linked and serial loans computed as at July 2020 in the attached file.Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/filarkiv/.For further information about data format and contents, please refer to the Nasdaq website.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.Yours sincerelyNykredit Realkredit A/SAttachmentsCash flow – Nykredit Realkredit – 09072020ydraek – 09072020

Continue reading

Canned Food Market to Reach USD 100.92 Billion by 2027; Increasing Number of Company Mergers and Acquisitions will Provide Impetus to Market Growth, says Fortune Business Insights™

Pune, July 09, 2020 (GLOBE NEWSWIRE) — The global canned food market size is projected to reach USD 100.92 billion by the end of 2027. Increasing product demand availability at low costs will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Canned Food Market Size, Share & COVID-19 Impact Analysis, By Type (Canned Seafood, Canned Fruits and Vegetables, Canned Meat, and Others), Distribution Channel (Supermarkets/ Hypermarkets, Specialty Stores, and Online Retail), and Regional Forecast, 2020 – 2027,” the market was worth USD 91.90 in 2019 and will exhibit a CAGR of 1.30% during the forecast period, 2020-2027.The novel coronavirus, COVID-19, has cast an unprecedented effect on several businesses across industries. While some industries are experiencing significant loss owing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.